LFMD vs. AUNA, INNV, PETQ, CELC, CDMO, KALV, OFIX, PROK, ALEC, and ABUS
Should you be buying LifeMD stock or one of its competitors? The main competitors of LifeMD include Auna (AUNA), InnovAge (INNV), PetIQ (PETQ), Celcuity (CELC), Avid Bioservices (CDMO), KalVista Pharmaceuticals (KALV), Orthofix Medical (OFIX), ProKidney (PROK), Alector (ALEC), and Arbutus Biopharma (ABUS). These companies are all part of the "medical" sector.
LifeMD (NASDAQ:LFMD) and Auna (NYSE:AUNA) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their community ranking, dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.
Auna has a net margin of 0.00% compared to LifeMD's net margin of -14.01%.
35.5% of LifeMD shares are owned by institutional investors. 18.9% of LifeMD shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
In the previous week, LifeMD had 5 more articles in the media than Auna. MarketBeat recorded 10 mentions for LifeMD and 5 mentions for Auna. Auna's average media sentiment score of 0.54 beat LifeMD's score of 0.19 indicating that Auna is being referred to more favorably in the news media.
LifeMD presently has a consensus target price of $11.60, indicating a potential upside of 24.73%. Auna has a consensus target price of $14.15, indicating a potential upside of 66.47%. Given Auna's higher possible upside, analysts plainly believe Auna is more favorable than LifeMD.
Auna has lower revenue, but higher earnings than LifeMD.
LifeMD received 21 more outperform votes than Auna when rated by MarketBeat users. However, 100.00% of users gave Auna an outperform vote while only 69.44% of users gave LifeMD an outperform vote.
Summary
LifeMD beats Auna on 6 of the 11 factors compared between the two stocks.
Get LifeMD News Delivered to You Automatically
Sign up to receive the latest news and ratings for LFMD and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding LFMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
